Leah Rosenbaum, Forbes Staff

Author's posts

Moderna Gets 3% Stock Boost From Early Clinical Data

Moderna shared interim data from two phase one clinical trials today, leading to a bump in its stock price.

Drug Prices Keep Rising Amid Political Pressure, But Not As Fast

Prices for the majority of drugs in the U. S. have started to rise more slowly, likely a result of public and political pressure.

FDA Warns Juul About Deceptive Marketing Tactics

The U. S. Food and Drug Administration on Monday accused Juul of deceptive marketing practices for presenting their vaping products as safer than conventional cigarettes.

NIH Awards Color $4.6 Million As Genetic Counselor Provider for 1 Million Person Study

Color received a $4.6 million grant to collaborate with the National Institutes of Health’s “All of Us” research program.

How This Video Game Company Will Help Keep Mars Astronauts Healthy

On Wednesday, Level Ex announced that it received a year-long grant from the Translational Research Institute for Space Health to create simulations of human health in space.

EPA Rejects Ban On Common Pesticide Linked to Brain Damage in Children

On Thursday the EPA decided not to ban a controversial pesticide that has been linked to health risks in children.